# 1. Financial Performance ## A. Key Figures * **Net Revenue:** **₹321 Cr** Q2 FY'26 (-4.5% QoQ) · **₹657 Cr** H1 FY'26 (-10.6% YoY) * **Operating EBITDA:** **₹22 Cr** Q2 FY'26 (7%) · **₹53 Cr** H1 FY'26 (1%) (-33% YoY) * **Operating PBT:** **₹19 Cr** Q2 FY'26 · **₹42 Cr** H1 FY'26 (-39% YoY) * **PAT:** **₹29 Cr** H1 FY'26 (-58% YoY) ## B. Revenue Trends * **Pricing Pressure Dominates:** Revenue decline driven by **competitive import-led pricing pressure**, only partially offset by lower raw material costs. * **Sequential Volume Stability:** Despite lower prices, sequential revenue drop was contained, suggesting **resilient volume performance** amid challenging market conditions. ## C. Profit Margins * **Margin Compression Intensifies:** EBITDA and PBT margins contracted significantly YoY, reflecting both **top-line pressure** and absence of prior-year tax benefits. * **Prior-Year Tax Benefit Skews Comparison:** H1 FY'25 PAT included a **₹15 Cr deferred tax credit** from LTCG rate remeasurement, creating a difficult base for YoY earnings comparison. ## D. Cash Flow Health * **Working Capital Discipline:** Operating cash flow improved due to **focused optimization of working capital**, supporting liquidity despite weak earnings. ## E. Balance Sheet Position * **Net Cash Maintained:** Company retains a **net cash position** and has **shortened working capital cycle**, providing resilience amid soft demand outlook. * **North America Headwinds:** CV OEM demand in North America expected to remain weak until **mid-2026**, prolonging sectoral challenges. * **Dumping Duty Uncertainty:** Management refrains from comment on anti-dumping case, citing **sub judice status**; awaits DGTR final recommendations. --- # 2. Volume & Market Share ## A. Key Figures * **Q2 FY'26 Sales Volume:** **138** (Q1 FY'20 = 100) * **Volume Split:** **~67% domestic** · **~33% exports** * **Domestic Market Size:** **80,000–85,000 tons/year** * **Market Share:** **38–40%** (domestic rubber chemicals) ## B. Domestic Volumes * **Resilient Sequential Growth:** Domestic volumes posted strong quarter-on-quarter expansion despite macro headwinds, including GST 0 rollout and global dumping pressures. * **Recovery Trajectory:** Management expects full-year volume growth despite H1 decline, supported by improving domestic demand dynamics and GST-related tailwinds. * **Latex Volume Reset:** Current latex volumes remain significantly below peak pandemic levels, reflecting structural demand shifts. ## C. Export Volumes * **Near-Term Export Pressure:** Export volumes declined due to U.S. tariff disruptions and cautious buyer behavior, with choppy conditions expected to persist in the short term. * **D. S. Market Engagement:** NOCIL continues shipping to the U.S. amid active dialogue to navigate trade barriers and stabilize export flows. ## D. Market Share Trends * **Stable Competitive Position:** NOCIL maintains a consistent ~40% domestic market share, with no evidence of material erosion despite competitive intensity. * **Favorable Domestic Outlook:** Robust tire industry fundamentals, driven by infrastructure spending and reduced GST rates, support sustained demand for rubber chemicals. --- # 3. Product & Segment Performance ## A. Key Figures * **Latex Sales Mix:** **~8%** of total sales volume ## B. Latex Business * **Volume Decline:** Latex segment experienced YoY volume contraction in Q2, driven by **tariff uncertainties** in key markets, now resolving. * **Cyclical Context:** Current softness follows a relatively strong prior year, which itself rebounded from post-COVID lows, indicating a near-term cyclical dip. * **Strategic Positioning:** Latex products are **functionally unique** and not directly comparable to peers; relationships are long-duration once secured. ## C. Rubber Chemicals * **Competitive Edge:** Broader product portfolio enhances competitiveness versus Korean suppliers, who offer only **a single antioxidant product**, limiting their market reach despite lower prices. ## D. New Product Launches * **Launch Timeline:** New products are in **soft launch phase**, with commercial sales expected before end-FY26, though initial volumes will be constrained. * **Growth Pathway:** Management anticipates new offerings could become **substantial contributors** within 2–3 years, contingent on customer approvals and capacity scaling. --- # 4. Manufacturing & Utilization ## A. Key Figures * **Capacity Utilization:** ~65% current rate (10-year low in operating leverage) * **Working Capital Efficiency:** **20% improvement** in sales days efficiency ## B. Capacity Expansion * **TDQ Expansion on Schedule:** Dahej TDQ capacity expansion remains on track for commissioning and trial production in H1 2026. ## C. Utilization Rates * **Suboptimal Utilization Weighs on Leverage:** Current ~65% capacity utilization constrains fixed cost absorption, resulting in the weakest operating leverage benefits in a decade. ## D. Cost Efficiency * **Margin Resilience via Operational Levers:** Management is countering margin pressure through pricing, volume growth, and **multiple cost optimization initiatives** yielding near-term savings. * **Efficiency Gains Taking Hold:** Improvements in inventory management, production planning, and raw material handling are already reducing **per-kilo costs**, **power/fuel consumption**, and **conversion costs**. * **Conversion Cost Outlook:** Structural declines expected from Q4 FY'26 onward, though magnitude remains uncertain due to inflation and performance variability. --- # 5. Trade & Supply Chain ## A. Key Figures * **Imported Intermediate Usage:** **30%** of Indian finished product demand relies on imported penultimate intermediate from **China and EU** * **Inventory Resolution:** **90% to over 95%** of high-cost inventory issue resolved * **Procurement Lead Time:** **60–70 days** advance planning required due to import dependence * **B. S. Market Share:** **~9%** of global rubber chemicals demand ## B. Import Dependence * **Structural Vulnerability:** Most domestic producers remain exposed to foreign supply chains due to reliance on imported intermediates, creating logistical and pricing risks. * **Operational Constraint:** Extended procurement timelines—nearly 10-week lead times—highlight ongoing challenges in supply chain agility versus fully domestic models. ## C. Anti-dumping Filings * **Active Trade Remedies:** Antidumping petitions on key rubber chemical products accepted for investigation, with **positive engagement under DGTR rules** and reasonable confidence in favorable outcomes. * **Strategic Impact:** If implemented, duties could **curb Chinese import competitiveness**, supporting both pricing power and volume recovery, independent of FTA exemptions for countries like Korea. * **Execution Risk:** Despite DGTR recommendations on Chinese dumping, final duty imposition awaits **Finance Ministry approval**, introducing uncertainty amid broader diplomatic considerations. ## D. Global Supply Shifts * **Regional Demand Divergence:** Western markets remain weak, while Europe shows mild rebound on pre-emptive import activity; U.S. exports face **temporary tariff headwinds** but long-term solutions in progress. * **Competitive Positioning:** NOCIL differentiating via **supply reliability** and potential overseas stock points to retain customers despite pricing pressure. * **Emerging Rivalry:** Korea gaining share in select segments due to **lower tariff advantages** over China and India, altering competitive dynamics. --- # 6. Pricing & Competitive Risks ## A. Import Pricing Pressure * **Headline:** U.S. OE demand softens amid tariff uncertainties, while replacement demand holds steady, weighing on industry performance. * **Headline:** Korean exporters gaining share in antioxidants via **aggressive pricing below Chinese levels**, supported by India-Korea FTA advantages. * **Headline:** Tariffs have not reshaped market shares meaningfully, as **Europe retains dominance in U.S. supply** due to entrenched operations and trade dynamics. * **Headline:** Despite China facing **25% higher tariffs than India**, Indian suppliers have only achieved marginal cost competitiveness, limiting pricing leverage. * **Headline:** Landed cost—including tariff absorption—is decisive for U.S. procurement, making duty status a key gatekeeper for market participation. ## B. Competitor Behavior * **Headline:** NOCIL’s long-term customer relationships provide resilience against intense competition and predatory pricing tactics. * **Headline:** Market benchmarks distorted by **opportunistic and situational pricing**, creating perception of unrealistically low prices. * **Headline:** Speculation persists that some rivals may benefit from **external or government support**, enabling economically unsustainable pricing. * **Headline:** Indian producers are broadly cost-competitive vs. West, though delivered costs were previously **5–6% above Europe**, narrowing under current conditions. --- # 7. Guidance & Outlook ## A. Key Figures * **Capex (Dahej Expansion):** **₹250 Cr** project (~75–80% complete) · Trial production expected H1 CY'26 (Jan–Jun 2026) ## B. Volume Projections * **Long-Term Volume Strategy:** Growth trajectory remains intact with active customer penetration and market expansion, independent of antidumping duty (ADD) outcome. ## C. Margin Recovery * **Sustained Efficiency & Leverage:** Management expects current efficiency levels to persist in H2, with operating leverage improving as volumes rise. * **Margin Improvement Pathway:** Sequential profit improvement anticipated from incremental efficiency measures, though timing remains unspecified. * **Resilient Outlook:** Despite pricing pressure, NOCIL views current conditions as the "new normal" and remains positive on FY'27 growth. ## D. Capex Timeline * **Dahej Expansion on Track:** Trial runs set for H1 CY'26, with incremental commercial production expected by **mid-2026**.